522.47
Medpace Holdings Inc stock is traded at $522.47, with a volume of 9,328.
It is up +0.50% in the last 24 hours and up +16.02% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$520.00
Open:
$527.97
24h Volume:
9,328
Relative Volume:
0.03
Market Cap:
$14.92B
Revenue:
$2.53B
Net Income/Loss:
$451.12M
P/E Ratio:
34.16
EPS:
15.2927
Net Cash Flow:
$681.87M
1W Performance:
+0.37%
1M Performance:
+16.02%
6M Performance:
+1.61%
1Y Performance:
+71.34%
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings Inc
|
522.47 | 14.85B | 2.53B | 451.12M | 681.87M | 15.29 |
|
TMO
Thermo Fisher Scientific Inc
|
527.85 | 195.93B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
198.45 | 140.56B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.80 | 46.39B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.99 | 34.02B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
328.60 | 32.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-18-26 | Upgrade | TD Cowen | Sell → Hold |
| Feb-13-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-10-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Medpace Holdings Inc stock (US5840631062): Is its CRO execution strong enough to unlock new upside? - AD HOC NEWS
Investors Urged to Contact Robbins LLP Over Medpace Holdings Losses - National Today
A Look at Medpace Holdings Inc (MEDP) After 3.8% Gain -- GF Value $472.51 vs Price $520.00 - GuruFocus
Did You Lose Money Investing in Medpace Holdings Inc.? - GlobeNewswire
Did You Lose Money Investing in Medpace Holdings Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against MEDP - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, - GlobeNewswire
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lead Plaintiff Deadline of June 8, 2026 in Shareholder - GlobeNewswire
Medpace Holdings Sued for Securities Law Violations - National Today
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Why Medpace (MEDP) Outpaced the Stock Market Today - Yahoo Finance
Shareholders of Medpace Holdings, Inc. Should Contact Levi & Korsinsky Before June 8, 2026 ... - Bluefield Daily Telegraph
Shareholders of Medpace Holdings, Inc. Should Contact Levi - GlobeNewswire
FinancialContentDeadline Approaching: Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith - FinancialContent
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Pomerantz LLP Alerts Shareholders to Investor Suit Against Medpace Holdings, Inc. – MEDP - ACCESS Newswire
MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Medpace Investors Opportunity to Lead Lawsuit - National Today
MEDP INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit - The Daily Tribune News
Assessing Medpace Holdings (MEDP) Valuation After Recent Share Price Weakness - Yahoo Finance
Dorsey Wright & Associates's Medpace Holdings Inc(MEDP) Holding History - GuruFocus
MEDP Investors Have Opportunity to Lead Medpace Holdings Securities Fraud Lawsuit - National Today
Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Financial Times
Portnoy Law Firm Announces Class Action Against Medpace Holdings - National Today
Portnoy Law Firm Announces Class Action on Behalf of Medpace Holdings, Inc. Investors - GlobeNewswire
Buyout Rumor: Can Medpace Holdings Inc ride the EV wavePortfolio Return Summary & Real-Time Volume Analysis - baoquankhu1.vn
Medpace Holdings Inc (HAM:01P) Stock Price, Trades & News - GuruFocus
Shareholders Urged to Contact Law Firm After Medpace Stock Decline - National Today
MEDP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 - PR Newswire
Shareholders who lost money in Medpace Holdings, Inc. (NASDAQ: MEDP) Should Contact Wolf Haldenstein Immediately - Finviz
A Look at Medpace Holdings Inc (MEDP) After 3.7% Decline -- GF V - GuruFocus
Panic Selling: How does Medpace Holdings Inc perform in inflationary periodsMarket Sentiment Review & Capital Efficient Trading Techniques - baoquankhu1.vn
Law Offices of Howard G. Smith Encourages Medpace Holdings, Inc. (MEDP) Shareholders To Inquire About Securities Fraud Class Action - FinancialContent
Law Offices of Frank R. Cruz Encourages Medpace Holdings, Inc. (MEDP) Shareholders To Inquire About Securities Fraud Class Action - lincolnjournal.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming DeadlinesMEDP - PR Newswire
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Shareholders who lost money in Medpace Holdings, Inc. - GlobeNewswire
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit - Sahm
Risk Report: How does Medpace Holdings Inc perform in inflationary periodsPrice Action & Daily Growth Stock Tips - baoquankhu1.vn
S&P MidCap 400 Pure Growth Fund's Medpace Holdings Inc(MEDP) Holding History - GuruFocus
MEDP Stockholder Alert: Shareholder Rights Law Firm Robbins - GlobeNewswire
Medpace Holdings Investors Face Lawsuit Over Alleged Misleading Guidance on Key Business Metric - TipRanks
MEDP PE Ratio & Valuation, Is MEDP Overvalued - Intellectia AI
MEDP STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Rosen Law Firm Urges Medpace Stockholders to Contact Firm - National Today
Securities Fraud Investigation Into Medpace Holdings, Inc. (MEDP) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
Robbins LLP Informs Investors of Medpace Holdings Class Action - National Today
Investor Notice: Robbins LLP Informs Investors of the Medpace Holdings Inc. Class Action - PharmiWeb.com
MEDP Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Medpace Class Action Lawsuit – RGRD Law - marketscreener.com
MEDP INVESTOR ALERT: Medpace Holdings Inc. Investors with - GlobeNewswire
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):